Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 05, 2026
Global Gains: F45 Training Teams Up With Endurance Zone to Unveil New Loyalty Program For Members – FIT Rewards
08:30am, Wednesday, 03'rd Sep 2025
AUSTIN, Texas--(BUSINESS WIRE)--F45 Training, a leading global fitness community specializing in innovative, functional group workouts that are fast, fun, and results-driven, announced today the launc
Global X Selects ICE Indices for Four New ETFs in Canada
08:30am, Wednesday, 03'rd Sep 2025
ATLANTA & NEW YORK & TORONTO--(BUSINESS WIRE)--Intercontinental Exchange, Inc. (NYSE: ICE), a leading global provider of technology and data, today announced that ICE indices have been licensed by Glo
Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference
08:30am, Wednesday, 03'rd Sep 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to addres
Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio
08:25am, Wednesday, 03'rd Sep 2025
SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury compan
60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference
08:02am, Wednesday, 03'rd Sep 2025
WASHINGTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new
Twist Bioscience to Present at Baird 2025 Global Healthcare Conference
08:00am, Wednesday, 03'rd Sep 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder
Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
08:00am, Wednesday, 03'rd Sep 2025
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics
Opus Genetics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
08:00am, Wednesday, 03'rd Sep 2025
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gen
Algorhythm Holdings to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
08:00am, Wednesday, 03'rd Sep 2025
Fort Lauderdale, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm Holdings” or the “Company”) (NASDAQ: RIME), an AI technology holding company, today announced tha
Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference
08:00am, Wednesday, 03'rd Sep 2025
BOTHELL, Wash., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company over
Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
08:00am, Wednesday, 03'rd Sep 2025
GARDEN CITY, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused o
Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
07:45am, Wednesday, 03'rd Sep 2025
Clinical trial advances to anticipated final cohort for INSTASYL siRNA lead product candidate PH-762 5th cohort patients now being treated in on-going clinical study King of Prussia, Pennsylvania--(Ne
Zefiro Successfully Delivers Carbon Offsets to Global Wholesale Energy Leader EDF Trading
07:30am, Wednesday, 03'rd Sep 2025
In August, Zefiro issued some of the first carbon credits under the American Carbon Registry's Orphan Well Methodology reflecting confirmed emissions reductions of 92,956 metric tonnes of CO2 equivale
Arrive AI to Participate in H.C. Wainwright 27th Annual Global Investment Conference
07:21am, Wednesday, 03'rd Sep 2025
INDIANAPOLIS, INDIANA / ACCESS Newswire / September 3, 2025 / The executive team of Arrive AI (NASDAQ:ARAI), an autonomous delivery network anchored by patented AI-powered Arrive Points™, is schedul
Aldeyra Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
07:01am, Wednesday, 03'rd Sep 2025
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-medi
